Patents by Inventor Derek Anthony Rawlings

Derek Anthony Rawlings has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyridine Compounds For The Treatment Of Prostaglandin Mediated Diseases
    Publication number: 20100137378
    Abstract: Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein X, Y, Z, R2a, R2b, R3a, R3b, R8, R9, and Rx are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine (EP, —receptor antagonists).
    Type: Application
    Filed: December 21, 2005
    Publication date: June 3, 2010
    Applicant: GLAXO GROUP LIMITED
    Inventors: Gerard Martin Paul Giblin, Adrian Hall, David Nigel Hurst, Derek Anthony Rawlings, Tiziana Scoccitti
  • Pyrimidine Derivatives And Their Use As CB2 Modulators
    Publication number: 20100041654
    Abstract: This relates to novel pyrimidine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.
    Type: Application
    Filed: October 21, 2009
    Publication date: February 18, 2010
    Inventors: Andrew John Eatherton, Gerard Martin Paul Giblin, Richard Howard Green, Jennifer Margaret Doughty, William Leonard Mitchell, Alan Naylor, Derek Anthony Rawlings, Brian Peter Slingsby, Andrew Richard Whittington
  • Pyrimidine derivatives and their use as CB2 modulators
    Patent number: 7635701
    Abstract: The present invention relates to novel pyrimidine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.
    Type: Grant
    Filed: August 19, 2003
    Date of Patent: December 22, 2009
    Assignee: Glaxo Group Limited
    Inventors: Andrew John Eatherton, Gerard Martin Paul Giblin, Richard Howard Green, Jennifer Margaret Doughty, legal representative, William Leonard Mitchell, Alan Naylor, Derek Anthony Rawlings, Brian Peter Slingsby, Andrew Richard Whittington
  • 2-(Phenylamino)-Pyrimidin-5-Amides As Cannabinoid 2 Receptors Modulators for the Treatment of Immune or Inflammatory Disorders
    Publication number: 20090264452
    Abstract: The present invention relates to novel pyrimidine derivatives such as compounds of the formula (I): and the use of such compounds or pharmaceutical compositions thereof in the treatment of diseases, particularly pain, which are mediated by the activity of the cannabinoid 2 receptor.
    Type: Application
    Filed: February 1, 2005
    Publication date: October 22, 2009
    Inventors: Andrew John Eatherton, Gerard Martin Paul Giblin, William Leonard Mitchell, Alan Naylor, Derek Anthony Rawlings, Ian David Wall
  • PYRAZOLE COMPOUNDS AS PROSTAGLANDIN RECEPTORS LIGANDS
    Publication number: 20090239845
    Abstract: Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein Z, R1, R2a, R2b, R10, R11 and Rx are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.
    Type: Application
    Filed: April 24, 2006
    Publication date: September 24, 2009
    Inventors: Elizabeth Ann Conway, Gerard Martin Paul Giblin, Mairi Gibson, Adrian Hall, Thomas George Christopher Hayhow, Mark Patrick Healy, David Nigel Hurst, Ian Reginald Kilford, Stephen Carl McKeown, Alan Naylor, Helen Susanne Price, Derek Anthony Rawlings
  • Benzofuran Compounds As EP1 Receptor Antagonists
    Publication number: 20090099169
    Abstract: Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein R1, R2a, R2b, R2c, and R3 are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.
    Type: Application
    Filed: April 3, 2007
    Publication date: April 16, 2009
    Applicant: GLAXO GROUP LIMITED
    Inventors: Mairi Gibson, Adrian Hall, David Nigel Hurst, Derek Anthony Rawlings
  • Combination Of Cb2 Modulators And Pde4 Inhibitors For Use In Medicine
    Publication number: 20080132505
    Abstract: Combination of one or more CB2 modulators and one or more PDE4 inhibitors, and method of treating conditions which are mediated by the activity of CB2 receptors or conditions which are mediated by PDE4.
    Type: Application
    Filed: February 1, 2005
    Publication date: June 5, 2008
    Inventors: Andrew James Brown, Helen Elizabeht Connor, Andrew John Eatherton, Gerard Martin Paul Giblin, Richard Howard Green, Jennifer Margaret Doughty, Karamjit Singh Jandu, Richard Graham Knowles, William Leonard Mitchell, Alan Naylor, Celestine Theresa O'Shaughnessy, Giovanni Palombi, Derek Anthony Rawlings, Brian Peter Slingsby, Catherine Jane Tralau-Stewart, Andrew Richard Whittington, Richard Alexander Williamson
  • Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors
    Patent number: 7105532
    Abstract: The present invention relates to novel compounds, in particular to novel pyrazolopyridine derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds in medicine.
    Type: Grant
    Filed: December 19, 2001
    Date of Patent: September 12, 2006
    Assignee: SmithKline Beecham Corporation
    Inventors: Derek Anthony Rawlings, Jason Witherington
  • Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors
    Publication number: 20040077681
    Abstract: A compound of formula (I) or a derivative thereof, wherein R1 is unsubstituted or substituted alkyl, unsubstituted or substituted cycloalkyl, unsubstituted or substituted alkenyl, unsubstituted or substituted cycloalkenyl, unsubstituted or substituted aryl, aralkyl wherein the aryl and the alkyl moieties may each independently be unsubstituted or substituted, aralkenyl wherein the aryl and alkenyl moieties may each independently be unsubstituted or substituted, unsubstituted or substituted heterocyclyl, or heterocyclyalkyl wherein the heterocyclyl and the alkyl moieties may each independently be unsubstituted or substituted; and R2 is unsubstituted or substituted aryl or unsubstituted or substituted heteroaryl, a process for preparing such compounds, a pharmaceutical composition comprising such compounds and the use of such compounds and composition in medicine.
    Type: Application
    Filed: November 20, 2003
    Publication date: April 22, 2004
    Inventors: Derek Anthony Rawlings, Jason Witherington